Eu Yan Sang profit balloons 318% to S$1.4m

Recovery firmly on track.

According to OSK-DMG, strong sales growth in Hong Kong and Australia are propelling Eu Yan Sang (EYSAN) forward, helping it post a S$1.4m net profit during 1QFY14.

Near-term prospects look bright, with the research firm predicting FY14F-15F earnings to grow by 27-50% to S$18.7m-28.0m, respectively.

For 1QFY14, EYSAN recorded revenue of SGD80m fuelled mostly by a 26% rise in Hong Kong sales to SGD37m, buoyed by its strong retail and wholesale segments, said OSK-DMG.

"A higher number of Chinese tourists lifted demand for its Bo Ying Compound, a traditional Chinese remedy for paediatric discomfort, as well as other Eu Yan Sang branded products. Nonetheless, this was partially offset by a 2% dip in Singapore’s contribution (to S$17.5m) on cautious consumer spending. Sales in Australia rose 16% to S$9.9m, equivalent to a 30% increase in local currency terms," added OSK-DMG.

The research firm predicts further earnings improvements in the following 2Q and 3Q, with a predicted expansion of 16-14% yoy to SGD5.4m-9.6m for the respective periods.

Also Read

Singaporeans' physical well-being at highest level since 2019

SingHealth partners with OutcomesAI to integrate AI into medical workflows

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

I want to download the media kit